Calypte Biomedical Presents at Healthcare Conference.Business Editors NEW YORK--(BUSINESS WIRE)--Dec. 10, 2002 Calypte Biomedical bi·o·med·i·cal adj. 1. Of or relating to biomedicine. 2. Of, relating to, or involving biological, medical, and physical sciences. Corporation (OTCBB OTCBB See OTC Bulletin Board (OTCBB). : CALY), the developer and marketer of the only two FDA-approved HIV-1 antibody tests that can be used on urine samples, as well as an FDA-approved serum HIV-1 antibody Western Blot Western blot A technique developed in 1979 that is used to confirm ELISA results. HIV antigen is purified by electrophoresis and attached by blotting to a nylon or nitrocellulose filter. supplemental test, will present at the CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network Virtual Healthcare Conference co-sponsored by Lippert/Heilshorn & Associates and Red Chip Review on Tuesday, December 10th, 2002 at 3:00 pm ET (12:00 pm PT). This call is being webcast by CCBN and can be accessed at Calypte's web site www.calypte.com. The webcast is also being distributed over CCBN's Investor Distribution Network to both institutional and individual investors. Individual investor can listen to the call through CCBN's individual investor center at www.companyboardroom.com or by visiting any of the investor sites in CCBN's Individual Investor Network. Institutional investors Institutional Investor A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. can access the call via CCBN's password protected event management site, StreetEvents (www.streetevents.com). |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion